Medicamen Biotech Quarterly Results for Trading Insights
MEDICAMEQ • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹2 Cr
QSept 2025
Medicamen Biotech Quarterly Results Key Highlights
- Revenue of ₹48 Cr in Sept 2025 (+37.1% vs Mar 2025, +6.7% vs Sept 2024)
- Net Profit of ₹2 Cr in Sept 2025 (+0.0% vs Mar 2025, +100.0% vs Sept 2024)
- EBITDA of ₹6 Cr in Sept 2025 (+50.0% vs Mar 2025)
- Operating Margin of 11.0% in Sept 2025 (+16.0pp vs Mar 2025)
- Earnings Per Share of ₹1.56 in Sept 2025 (+6.1% vs Mar 2025)
Medicamen Biotech Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 48 | 35 | 44 | 45 | 48 | 37.1% | 6.7% |
| Net Profit (₹ Cr) | 2 | 2 | 2 | 1 | 2 | - | - |
| EBITDA (₹ Cr) | 6 | 4 | 5 | 6 | 6 | - | - |
| EPS (₹) | 1.56 | 1.47 | 1.18 | 0.71 | 1.61 | - | - |
| Operating Margin (%) | 11.0% | -5.0% | 11.0% | 12.0% | 12.0% | - | - |
Medicamen Biotech Share Price Trend Around Quarterly Results
Visualize Medicamen Biotech's 1-year price movement across quarterly results — ideal for logging trades in Medicamen Biotech share price
chart using Tickjournal. All values in ₹.
Related Pages for Medicamen Biotech
Additional stock information and data for MEDICAMEQ
Revenue Trend (₹ Cr)
Sept 2024
45
Jun 2025
44
Mar 2025
35
Sept 2025
48
Net Profit Trend (₹ Cr)
Sept 2024
1
Jun 2025
2
Mar 2025
2
Sept 2025
2
Operating Margin Trend (%)
Sept 2024
12.0%
Jun 2025
11.0%
Mar 2025
-5.0%
Sept 2025
11.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Medicamen Biotech quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores